Our livestock business encompasses the poultry, swine, ruminant segments and Veterinary Public Health to address the needs of livestock producers, livestock veterinarians, government officials and NGOs.
We provide vaccines, diagnostics, research services, technical expertise to ensure safe, affordable, abundant and sustainable quality poultry meat and eggs.
One of the most important elements at Boehringer Ingelheim is our responsibility to protecting the connection between human, animal and environmental health.
At Boehringer Ingelheim we're improving treatments for patients suffering from a range of cardiovascular conditions atrial fibrillation, stroke & blood clots.
Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
Learn more about diabetes and how Boehringer Ingelheim is working to research and develop newer, innovative diabetes medications to improve patients lives.
At Boehringer Ingelheim we are dedicated to working on improving treatments for cancer patients everywhere with a focus on lung and gastrointestinal cancers.
Learn about obesity & see what Boehringer Ingelheim is doing to develop new medications to improve patients lives. Read the latest obesity articles here.